EEA Life Settlements Fund PCC Limited (the Fund) – 2 January Redemptions of Continuing Shares

The Fund’s board of directors (the Board) has exercised its power to restrict redemptions of Shares in each Continuing Cell to the amount of Available Cash attributable to each such Continuing Cell. In calculating the level of Available Cash for each Cell at 31 December 2019, the Board exercised its discretion to exclude an amount consisting of cash and receivables to pay the premia on Current Underlying Investments for one year which means that, in aggregate, $30.56m was excluded across all Continuing and Run-Off Cells when determining the level of Available Cash.

In consequence, with the exception of the WAY Life Settlements Cell, there have been no redemptions of shares in the Continuing Cells and outstanding redemption requests in these Continuing Cells have been postponed until the next Redemption Day (i.e. until the 1 April 2020 Redemption Day), subject to further postponement if, on that day, a Cell’s outstanding redemption requests have an aggregate Redemption Value which exceeds the Available Cash held by the Cell as at such Redemption Day. Any such deferred redemptions will generally have priority over subsequent redemption requests, in accordance with the terms of the Fund’s Articles of Incorporation.

The Fund has redeemed $1,768.86 of shares for the Way Life Settlements Cell in respect of the 2 January 2020 Redemption Day.